Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
SIEGALL CLAY BCEO |
Buy | 20,434 @ $13.78 | $281,548 | 419,636 | 05/21/2024 | 05/21/2024 | |
BIENAIME JEAN JACQUESdirector |
Buy | 2,000 @ $13.57 | $27,140 | 9,615 | 05/21/2024 | 05/22/2024 | |
SIEGALL CLAY BCEO |
Buy | 79,566 @ $13.91 | $1.11 M | 399,202 | 05/20/2024 | 05/21/2024 | |
SIEGALL CLAY BCEO |
Buy | 169,204 @ $5.91 | $999,996 | 319,636 | 10/02/2023 | 10/04/2023 | |
Turner BruceChief Strategy Officer |
Buy | 42,300 @ $5.91 | $249,993 | 42,300 | 10/02/2023 | 10/04/2023 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|
A. The list of insiders at Immunome, Inc. includes Turner Bruce, SIEGALL CLAY B, BIENAIME JEAN JACQUES.
A. Insiders have purchased a total of 313,504 Immunome, Inc. shares in the last 12 months for a total of 2.67 M sold.
A. The following insiders have purchased Immunome, Inc. shares in the last 12 months: Turner Bruce ($249,993), SIEGALL CLAY B ($2.39 M), BIENAIME JEAN JACQUES ($27,140),